SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-24-000037
Filing Date
2024-01-08
Accepted
2024-01-08 08:30:07
Documents
14
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nhwk_8k.htm   iXBRL 8-K 29465
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 14203
  Complete submission text file 0001079973-24-000037.txt   265397

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nhwk-20240108.xsd EX-101.SCH 3534
4 XBRL DEFINITION FILE nhwk-20240108_def.xml EX-101.DEF 26569
5 XBRL LABEL FILE nhwk-20240108_lab.xml EX-101.LAB 36527
6 XBRL PRESENTATION FILE nhwk-20240108_pre.xml EX-101.PRE 25193
8 EXTRACTED XBRL INSTANCE DOCUMENT nhwk_8k_htm.xml XML 5025
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 24518483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)